A dozen House Republicans bucked Trump and Speaker Mike Johnson to prevent the legislation from advancing on the floor -- joining the entire Democratic caucus -- and, at least temporarily, freezing activity in the House. The final tally was 196-223.

There's been a lot of talk about why C.J. Gardner-Johnson was traded from the Eagles to the Texans. The safety joined "The Pivot" to discuss that and the story behind his Super Bowl parade shirt.

Johnson & Johnson ( JNJ 0.01%) has been a leading healthcare company in the world for decades, and it's one of the most valuable as well, with a market cap of around $380 billion. Known for its long-term stability and dividend growth, it's a blue chip stock that is primarily suitable for risk-averse investors who want to collect a reliable payout.

Ahead of the Philadelphia Eagles’ victory in the 2025 Super Bowl, questions began to swirl about a few of the team’s most important veterans. Retirement rumors had picked up steam in the latter part of the season,

Ben Johnson is entering his first season as head coach of the Chicago Bears. But where does he rank among the rest of the NFL coaches?

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

According to a July 10, 2025 SEC filing, the firm exited its entire position in Johnson & Johnson during Q2 2025, selling all 38,037 shares for $6,308,131 in reported transaction value. Andrew Hill Investment Advisors no longer holds JNJ shares as of June 30, 2025, based on 13F disclosures.

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research reiterated an ‘Outperform’ rating on the stock and a $175 price target. The bullish stance underscores the company’s strong performance year to date amid soaring regulatory concerns.